Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 48

1.

Rubella Vaccine-A Tale of Appropriate Caution and Remarkable Success.

Zimmerman LA, Reef SE, Orenstein WA.

JAMA Pediatr. 2018 Jan 1;172(1):95-96. doi: 10.1001/jamapediatrics.2017.4178. No abstract available.

2.

Progress in Rubella and Congenital Rubella Syndrome Control and Elimination - Worldwide, 2000-2016.

Grant GB, Reef SE, Patel M, Knapp JK, Dabbagh A.

MMWR Morb Mortal Wkly Rep. 2017 Nov 17;66(45):1256-1260. doi: 10.15585/mmwr.mm6645a4.

3.

Hospital-based surveillance of congenital rubella syndrome in Indonesia.

Herini ES, Gunadi, Triono A, Mulyadi AW, Mardin N, Rusipah, Soenarto Y, Reef SE.

Eur J Pediatr. 2017 Mar;176(3):387-393. doi: 10.1007/s00431-017-2853-8. Epub 2017 Jan 13.

PMID:
28091778
4.

Estimating the burden of rubella virus infection and congenital rubella syndrome through a rubella immunity assessment among pregnant women in the Democratic Republic of the Congo: Potential impact on vaccination policy.

Alleman MM, Wannemuehler KA, Hao L, Perelygina L, Icenogle JP, Vynnycky E, Fwamba F, Edidi S, Mulumba A, Sidibe K, Reef SE.

Vaccine. 2016 Dec 12;34(51):6502-6511. doi: 10.1016/j.vaccine.2016.10.059. Epub 2016 Nov 17.

5.

Using Seroprevalence and Immunisation Coverage Data to Estimate the Global Burden of Congenital Rubella Syndrome, 1996-2010: A Systematic Review.

Vynnycky E, Adams EJ, Cutts FT, Reef SE, Navar AM, Simons E, Yoshida LM, Brown DW, Jackson C, Strebel PM, Dabbagh AJ.

PLoS One. 2016 Mar 10;11(3):e0149160. doi: 10.1371/journal.pone.0149160. eCollection 2016. Review.

6.

Global Progress Toward Rubella and Congenital Rubella Syndrome Control and Elimination - 2000-2014.

Grant GB, Reef SE, Dabbagh A, Gacic-Dobo M, Strebel PM.

MMWR Morb Mortal Wkly Rep. 2015 Sep 25;64(37):1052-5. doi: 10.15585/mmwr.mm6437a5.

7.

Synthesis of Evidence to Characterize National Measles and Rubella Exposure and Immunization Histories.

Thompson KM, Odahowski CL, Goodson JL, Reef SE, Perry RT.

Risk Anal. 2016 Jul;36(7):1427-58. doi: 10.1111/risa.12454. Epub 2015 Aug 6.

PMID:
26249328
8.

Identification of Serologic Markers for School-Aged Children With Congenital Rubella Syndrome.

Hyde TB, Sato HK, Hao L, Flannery B, Zheng Q, Wannemuehler K, Ciccone FH, de Sousa Marques H, Weckx LY, Sáfadi MA, de Oliveira Moraes E, Pinhata MM, Olbrich Neto J, Bevilacqua MC, Tabith Junior A, Monteiro TA, Figueiredo CA, Andrus JK, Reef SE, Toscano CM, Castillo-Solorzano C, Icenogle JP; CRS Biomarker Study Group.

J Infect Dis. 2015 Jul 1;212(1):57-66. doi: 10.1093/infdis/jiu604. Epub 2014 Oct 31.

9.

Systematic Review of the Manifestations of Congenital Rubella Syndrome in Infants and Characterization of Disability-Adjusted Life Years (DALYs).

Simons EA, Reef SE, Cooper LZ, Zimmerman L, Thompson KM.

Risk Anal. 2016 Jul;36(7):1332-56. doi: 10.1111/risa.12263. Epub 2014 Aug 12. Review.

PMID:
25115193
10.

Characterization of the Risks of Adverse Outcomes Following Rubella Infection in Pregnancy.

Thompson KM, Simons EA, Badizadegan K, Reef SE, Cooper LZ.

Risk Anal. 2016 Jul;36(7):1315-31. doi: 10.1111/risa.12264. Epub 2014 Aug 5. Review.

PMID:
25100307
11.

Elimination of endemic measles, rubella, and congenital rubella syndrome from the Western hemisphere: the US experience.

Papania MJ, Wallace GS, Rota PA, Icenogle JP, Fiebelkorn AP, Armstrong GL, Reef SE, Redd SB, Abernathy ES, Barskey AE, Hao L, McLean HQ, Rota JS, Bellini WJ, Seward JF.

JAMA Pediatr. 2014 Feb;168(2):148-55. doi: 10.1001/jamapediatrics.2013.4342.

PMID:
24311021
12.

The estimated mortality impact of vaccinations forecast to be administered during 2011-2020 in 73 countries supported by the GAVI Alliance.

Lee LA, Franzel L, Atwell J, Datta SD, Friberg IK, Goldie SJ, Reef SE, Schwalbe N, Simons E, Strebel PM, Sweet S, Suraratdecha C, Tam Y, Vynnycky E, Walker N, Walker DG, Hansen PM.

Vaccine. 2013 Apr 18;31 Suppl 2:B61-72. doi: 10.1016/j.vaccine.2012.11.035. Review.

PMID:
23598494
13.

Reducing the global burden of congenital rubella syndrome.

Reef SE, Chu SY, Cochi SL, Kezaala R, van den Ent M, Gay A, de Quadros C, Strebel PM.

Lancet. 2012 Sep 29;380(9848):1145-6. doi: 10.1016/S0140-6736(12)61663-8. No abstract available.

PMID:
23021280
14.

Measles, rubella, and varicella among the crew of a cruise ship sailing from Florida, United States, 2006.

Mitruka K, Felsen CB, Tomianovic D, Inman B, Street K, Yambor P, Reef SE.

J Travel Med. 2012 Jul;19(4):233-7. doi: 10.1111/j.1708-8305.2012.00620.x.

15.

Rubella vaccination of unknowingly pregnant women during mass campaigns for rubella and congenital rubella syndrome elimination, the Americas 2001-2008.

Castillo-Solórzano C, Reef SE, Morice A, Vascones N, Chevez AE, Castalia-Soares R, Torres C, Vizzotti C, Ruiz Matus C.

J Infect Dis. 2011 Sep 1;204 Suppl 2:S713-7. doi: 10.1093/infdis/jir489.

PMID:
21954271
16.

Guidelines for the documentation and verification of measles, rubella, and congenital rubella syndrome elimination in the region of the Americas.

Castillo-Solórzano C, Reef SE, Morice A, Andrus JK, Ruiz Matus C, Tambini G, Gross-Galiano S.

J Infect Dis. 2011 Sep 1;204 Suppl 2:S683-9. doi: 10.1093/infdis/jir471.

PMID:
21954267
17.

Virologic surveillance for wild-type rubella viruses in the Americas.

Icenogle JP, Siqueira MM, Abernathy ES, Lemos XR, Fasce RA, Torres G, Reef SE.

J Infect Dis. 2011 Sep 1;204 Suppl 2:S647-51. doi: 10.1093/infdis/jir431.

PMID:
21954261
18.

Evidence used to support the achievement and maintenance of elimination of rubella and congenital rubella syndrome in the United States.

Reef SE, Redd SB, Abernathy E, Kutty P, Icenogle JP.

J Infect Dis. 2011 Sep 1;204 Suppl 2:S593-7. doi: 10.1093/infdis/jir420.

PMID:
21954252
19.

Progress toward measles and rubella elimination in Egypt.

El Sayed N, Kandeel N, Barakat I, Moussa I, Alexander JP Jr, Naouri B, Reef SE.

J Infect Dis. 2011 Jul;204 Suppl 1:S318-24. doi: 10.1093/infdis/jir123.

PMID:
21666180
20.

Progress toward control of rubella and prevention of congenital rubella syndrome--worldwide, 2009.

Reef SE, Strebel P, Dabbagh A, Gacic-Dobo M, Cochi S.

J Infect Dis. 2011 Jul;204 Suppl 1:S24-7. doi: 10.1093/infdis/jir155.

PMID:
21666168
21.

Guidance for isolation precautions for mumps in the United States: a review of the scientific basis for policy change.

Kutty PK, Kyaw MH, Dayan GH, Brady MT, Bocchini JA, Reef SE, Bellini WJ, Seward JF.

Clin Infect Dis. 2010 Jun 15;50(12):1619-28. doi: 10.1086/652770. Review.

PMID:
20455692
22.

Measles outbreak associated with an international youth sporting event in the United States, 2007.

Chen TH, Kutty P, Lowe LE, Hunt EA, Blostein J, Espinoza R, Dykewicz CA, Redd S, Rota JS, Rota PA, Lute JR, Lurie P, Nguyen MD, Moll M, Reef SE, Sinclair JR, Bellini WJ, Seward JF, Ostroff SM.

Pediatr Infect Dis J. 2010 Sep;29(9):794-800. doi: 10.1097/INF.0b013e3181dbaacf.

PMID:
20400927
23.

Persistence of rubella antibodies after 2 doses of measles-mumps-rubella vaccine.

LeBaron CW, Forghani B, Matter L, Reef SE, Beck C, Bi D, Cossen C, Sullivan BJ.

J Infect Dis. 2009 Sep 15;200(6):888-99. doi: 10.1086/605410.

PMID:
19659440
24.

Teratology: from science to birth defects prevention.

Rasmussen SA, Erickson JD, Reef SE, Ross DS.

Birth Defects Res A Clin Mol Teratol. 2009 Jan;85(1):82-92. doi: 10.1002/bdra.20506. Review.

PMID:
19067401
25.

Congenital rubella syndrome in a child born to Liberian refugees: clinical and public health perspectives.

Plotinsky RN, Talbot EA, Kellenberg JE, Reef SE, Buseman SK, Wright KD, Modlin JF.

Clin Pediatr (Phila). 2007 May;46(4):349-55.

PMID:
17475995
26.

Efforts at rubella elimination in the United States: the impact of hemispheric rubella control.

Dayan GH, Castillo-Solórzano C, Nava M, Hersh BS, Andrus J, Rodriguez R, Reef SE.

Clin Infect Dis. 2006 Nov 1;43 Suppl 3:S158-63.

PMID:
16998776
27.

Adequacy of surveillance to detect endemic rubella transmission in the United States.

Averhoff F, Zucker J, Vellozzi C, Redd S, Woodfill C, Waterman S, Baggs J, Weinberg M, Rodriquez-Lainz A, Carrion V, Goto C, Reef SE.

Clin Infect Dis. 2006 Nov 1;43 Suppl 3:S151-7.

PMID:
16998775
28.

Rubella immunity levels in the United States population: has the threshold of viral elimination been reached?

Hyde TB, Kruszon-Moran D, McQuillan GM, Cossen C, Forghani B, Reef SE.

Clin Infect Dis. 2006 Nov 1;43 Suppl 3:S146-50. Erratum in: Clin Infect Dis. 2008 Mar 15;46(6):962.

PMID:
16998774
29.

Genetic analysis of rubella viruses found in the United States between 1966 and 2004: evidence that indigenous rubella viruses have been eliminated.

Icenogle JP, Frey TK, Abernathy E, Reef SE, Schnurr D, Stewart JA.

Clin Infect Dis. 2006 Nov 1;43 Suppl 3:S133-40.

PMID:
16998772
30.

The epidemiological profile of rubella and congenital rubella syndrome in the United States, 1998-2004: the evidence for absence of endemic transmission.

Reef SE, Redd SB, Abernathy E, Zimmerman L, Icenogle JP.

Clin Infect Dis. 2006 Nov 1;43 Suppl 3:S126-32.

PMID:
16998771
31.

The evidence for the elimination of rubella and congenital rubella syndrome in the United States: a public health achievement.

Reef SE, Cochi SL.

Clin Infect Dis. 2006 Nov 1;43 Suppl 3:S123-5. No abstract available.

PMID:
16998770
32.

Elimination of rubella from the United States: a milestone on the road to global elimination.

Meissner HC, Reef SE, Cochi S.

Pediatrics. 2006 Mar;117(3):933-5. No abstract available.

PMID:
16510677
33.

Adverse events associated with smallpox vaccination in the United States, January-October 2003.

Casey CG, Iskander JK, Roper MH, Mast EE, Wen XJ, Török TJ, Chapman LE, Swerdlow DL, Morgan J, Heffelfinger JD, Vitek C, Reef SE, Hasbrouck LM, Damon I, Neff L, Vellozzi C, McCauley M, Strikas RA, Mootrey G.

JAMA. 2005 Dec 7;294(21):2734-43.

PMID:
16333009
34.

Development of a rubella vaccination strategy: contribution of a rubella susceptibility study of women of childbearing age in Kyrgyzstan, 2001.

Malakmadze N, Zimmerman LA, Uzicanin A, Shteinke L, Caceres VM, Kasymbekova K, Sozina I, Glasser JW, Joldubaeva M, Aidyralieva C, Icenogle JP, Strebel PM, Reef SE.

Clin Infect Dis. 2004 Jun 15;38(12):1780-3. Epub 2004 May 17.

PMID:
15227627
35.

Identifying risk factors for rubella susceptibility in a population at risk in the United States.

Danovaro-Holliday MC, Gordon ER, Woernle C, Higginbotham GH, Judy RH, Icenogle JP, Reef SE.

Am J Public Health. 2003 Feb;93(2):289-91. No abstract available.

36.

Commentary: Ongoing debate over the safety of the different mumps vaccine strains impacts mumps disease control.

Fullerton KE, Reef SE.

Int J Epidemiol. 2002 Oct;31(5):983-4. No abstract available.

PMID:
12435772
37.

The changing epidemiology of rubella in the 1990s: on the verge of elimination and new challenges for control and prevention.

Reef SE, Frey TK, Theall K, Abernathy E, Burnett CL, Icenogle J, McCauley MM, Wharton M.

JAMA. 2002 Jan 23-30;287(4):464-72.

PMID:
11798368
38.

Preventing congenital rubella syndrome (CRS) through vaccination of susceptible women of childbearing age.

Danovaro-Holliday MC, Zimmerman L, Reef SE.

J Womens Health Gend Based Med. 2001 Sep;10(7):617-9. No abstract available.

PMID:
11571090
39.
40.

A large rubella outbreak with spread from the workplace to the community.

Danovaro-Holliday MC, LeBaron CW, Allensworth C, Raymond R, Borden TG, Murray AB, Icenogle JP, Reef SE.

JAMA. 2000 Dec 6;284(21):2733-9.

PMID:
11105178
41.

Preparing for elimination of congenital Rubella syndrome (CRS): summary of a workshop on CRS elimination in the United States.

Reef SE, Plotkin S, Cordero JF, Katz M, Cooper L, Schwartz B, Zimmerman-Swain L, Danovaro-Holliday MC, Wharton M.

Clin Infect Dis. 2000 Jul;31(1):85-95. Epub 2000 Jul 25.

PMID:
10913402
42.

Rubella and congenital rubella syndrome.

Reef SE.

Bull World Health Organ. 1998;76 Suppl 2:156-7. No abstract available.

43.

Changing epidemiology of congenital rubella syndrome in the United States.

Schluter WW, Reef SE, Redd SC, Dykewicz CA.

J Infect Dis. 1998 Sep;178(3):636-41.

PMID:
9728530
44.

Nonperinatal nosocomial transmission of Candida albicans in a neonatal intensive care unit: prospective study.

Reef SE, Lasker BA, Butcher DS, McNeil MM, Pruitt R, Keyserling H, Jarvis WR.

J Clin Microbiol. 1998 May;36(5):1255-9.

45.

A coccidioidomycosis outbreak following the Northridge, Calif, earthquake.

Schneider E, Hajjeh RA, Spiegel RA, Jibson RW, Harp EL, Marshall GA, Gunn RA, McNeil MM, Pinner RW, Baron RC, Burger RC, Hutwagner LC, Crump C, Kaufman L, Reef SE, Feldman GM, Pappagianis D, Werner SB.

JAMA. 1997 Mar 19;277(11):904-8.

PMID:
9062329
46.
47.

Herpesvirus infections in persons infected with human immunodeficiency virus.

Stewart JA, Reef SE, Pellett PE, Corey L, Whitley RJ.

Clin Infect Dis. 1995 Aug;21 Suppl 1:S114-20. Review.

PMID:
8547499
48.

Treatment options for vulvovaginal candidiasis, 1993.

Reef SE, Levine WC, McNeil MM, Fisher-Hoch S, Holmberg SD, Duerr A, Smith D, Sobel JD, Pinner RW.

Clin Infect Dis. 1995 Apr;20 Suppl 1:S80-90. Review.

PMID:
7795112

Supplemental Content

Support Center